Titre : Visiteurs des patients

Visiteurs des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Antithrombin III Deficiency

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer l'impact des visites sur le patient ?

L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel.
Évaluation Bien-être Visiteurs
#2

Quels signes indiquent qu'un patient a besoin de visites ?

Un patient peut montrer des signes de solitude, d'anxiété ou de dépression.
Solitude Anxiété Dépression

Symptômes 2

#1

Quels symptômes peuvent s'aggraver sans visites ?

L'isolement social peut aggraver l'anxiété et la dépression chez le patient.
Isolement social Anxiété Dépression
#2

Les visites peuvent-elles réduire la douleur perçue ?

Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur.
Douleur Soutien émotionnel Visiteurs

Prévention 2

#1

Comment prévenir l'isolement des patients ?

Encourager les visites régulières et utiliser des technologies de communication.
Isolement Visites Technologie
#2

Quelles mesures prendre pour des visites sûres ?

Respecter les protocoles d'hygiène et les restrictions de visite en place.
Hygiène Protocoles Visiteurs

Traitements 2

#1

Les visites font-elles partie du traitement ?

Oui, les visites peuvent être considérées comme un complément au traitement médical.
Traitement Soutien social Visiteurs
#2

Comment les hôpitaux gèrent-ils les visites ?

Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients.
Gestion des visites Sécurité Hôpital

Complications 2

#1

Quelles complications peuvent survenir sans visites ?

L'absence de visites peut entraîner une détérioration de la santé mentale et physique.
Complications Santé mentale Santé physique
#2

Les visites peuvent-elles causer du stress au patient ?

Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress.
Stress Visiteurs Planification

Facteurs de risque 2

#1

Quels facteurs augmentent le besoin de visites ?

L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin.
Âge avancé Maladies chroniques Isolement social
#2

Les patients en soins intensifs ont-ils plus besoin de visites ?

Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs.
Soins intensifs Soutien Visiteurs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Visiteurs des patients : Questions médicales les plus fréquentes", "headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Visiteurs des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Visiteurs des patients", "alternateName": "Visitors to Patients", "code": { "@type": "MedicalCode", "code": "D014789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samantha J Chiew", "url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Paul H Hemsworth", "url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Sally L Sherwen", "url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen", "affiliation": { "@type": "Organization", "name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia." } }, { "@type": "Person", "name": "Grahame J Coleman", "url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Vicky Melfi", "url": "https://questionsmedicales.fr/author/Vicky%20Melfi", "affiliation": { "@type": "Organization", "name": "Hartpury University and Hartpury College, Gloucester, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Management of Antithrombin Deficiency in Pregnancy.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36323279", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1841-0399" } }, { "@type": "ScholarlyArticle", "name": "Antithrombin III Levels and Outcomes Among Patients With Trauma.", "datePublished": "2024-08-01", "url": "https://questionsmedicales.fr/article/39145978", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.27786" } }, { "@type": "ScholarlyArticle", "name": "Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36764659", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtha.2023.01.037" } }, { "@type": "ScholarlyArticle", "name": "Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis.", "datePublished": "2023-10-04", "url": "https://questionsmedicales.fr/article/37794095", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-43941-x" } }, { "@type": "ScholarlyArticle", "name": "Analysis of phenotype and gene mutation in three pedigrees with inherited antithrombin deficiency.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36268972", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jcla.24732" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Visiteurs des patients", "item": "https://questionsmedicales.fr/mesh/D014789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Visiteurs des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Visiteurs des patients", "description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Visiteurs des patients", "description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Visiteurs des patients", "description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Visiteurs des patients", "description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Visiteurs des patients", "description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Visiteurs des patients", "description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Antithrombin+III+Deficiency#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des visites sur le patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel." } }, { "@type": "Question", "name": "Quels signes indiquent qu'un patient a besoin de visites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression." } }, { "@type": "Question", "name": "Quels symptômes peuvent s'aggraver sans visites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient." } }, { "@type": "Question", "name": "Les visites peuvent-elles réduire la douleur perçue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur." } }, { "@type": "Question", "name": "Comment prévenir l'isolement des patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les visites régulières et utiliser des technologies de communication." } }, { "@type": "Question", "name": "Quelles mesures prendre pour des visites sûres ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les protocoles d'hygiène et les restrictions de visite en place." } }, { "@type": "Question", "name": "Les visites font-elles partie du traitement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les visites peuvent être considérées comme un complément au traitement médical." } }, { "@type": "Question", "name": "Comment les hôpitaux gèrent-ils les visites ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans visites ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique." } }, { "@type": "Question", "name": "Les visites peuvent-elles causer du stress au patient ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de visites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin." } }, { "@type": "Question", "name": "Les patients en soins intensifs ont-ils plus besoin de visites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Samantha J Chiew

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Paul H Hemsworth

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Sally L Sherwen

3 publications dans cette catégorie

Affiliations :
  • Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia.
Publications dans "Visiteurs des patients" :

Grahame J Coleman

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Vicky Melfi

2 publications dans cette catégorie

Affiliations :
  • Hartpury University and Hartpury College, Gloucester, United Kingdom.
Publications dans "Visiteurs des patients" :

Yongchao Hou

2 publications dans cette catégorie

Affiliations :
  • Emergency Department, ShanXi Provincial People's Hospital, Taiyuan, ShanXi, China.
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Melissa Corbally

2 publications dans cette catégorie

Affiliations :
  • School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Fiona Timmins

2 publications dans cette catégorie

Affiliations :
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Jocelyn A Srigley

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jocelyn.srigley@cw.bc.ca.

Amy Damashek

2 publications dans cette catégorie

Affiliations :
  • Western Michigan University, Kalamazoo, USA.
Publications dans "Visiteurs des patients" :

Emily A Vargas

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Publications dans "Visiteurs des patients" :

Ramaswami Mahalingam

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Riley A Marshall

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Mark Otieno

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
  • Department of Agricultural Resource Management, University of Embu, Embu, Kenya.
Publications dans "Visiteurs des patients" :

Neelendra Joshi

1 publication dans cette catégorie

Affiliations :
  • Department of Entomology and Plant Pathology, University of Arkansas at Fayetteville, Fayetteville, AR, USA.
Publications dans "Visiteurs des patients" :

Benjamin Rutschmann

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
Publications dans "Visiteurs des patients" :

Audra N Iness

1 publication dans cette catégorie

Affiliations :
  • Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, Va; Department of Pediatrics, Baylor College of Medicine, Houston, Tex. Electronic address: audra.iness@bcm.edu.

Jefferson O Abaricia

1 publication dans cette catégorie

Affiliations :
  • Department of Bioengineering, College of Engineering, Virginia Commonwealth University, Richmond, Va.

Wendemi Sawadogo

1 publication dans cette catégorie

Affiliations :
  • Division of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, Va.

Caleb M Iness

1 publication dans cette catégorie

Affiliations :
  • School of Medicine, California Northstate University, Elk Grove, Calif.

Sources (10000 au total)

Antithrombin III Levels and Outcomes Among Patients With Trauma.

Patients with trauma exhibit a complex balance of coagulopathy manifested by both bleeding and thrombosis. Antithrombin III is a plasma protein that functions as an important regulator of coagulation.... To assess whether changes in antithrombin III activity are associated with thrombohemorrhagic complications among patients with trauma.... This cohort study was conducted from December 2, 2015, to March 24, 2017, at a level I trauma center. A total of 292 patients with trauma were followed up from their arrival through 6 days from admiss... The primary study outcome measurements were associations between antithrombin III levels and outcomes among patients with trauma, including ventilator-free days, hospital-free days, intensive care uni... The 292 patients had a mean (SD) age of 54.4 (19.0) years and included 211 men (72.2%). Patients with an antithrombin III deficiency had fewer mean (SD) ventilator-free days (27.8 [5.1] vs 29.6 [1.4];... In this cohort study of patients with trauma, antithrombin III deficiency was associated with greater injury severity, increased hemorrhage, and increased mortality, as well as fewer ventilator-free, ...

Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository.

The natural history and genotype-phenotype correlation of congenital antithrombin (AT) deficiency in children are unknown.... To describe the clinical presentation of congenital AT deficiency in children and evaluate its correlation to specific mutations in SERPINC1.... In 2017, a prospective pediatric database and DNA biorepository for congenital AT deficiency was established. During the pilot phase, the database was opened at 4 tertiary care centers in Canada and U... Overall, 43 participants (25 females) from 31 unique kindreds were enrolled. Median age (range) at enrollment was 14.8 years (1-21 years). Median AT activity was 52% (24%-87%), and median AT antigen (... To our knowledge, this is the first pediatric study to document a severe thrombotic phenotype in carriers of null mutations in SERPINC1, when compared with carriers of missense mutations; underscoring...

Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis.

Antithrombin (AT) deficiency increases the risk for venous thromboembolism, therefore, a highly sensitive assay to identify this condition is crucial. The aim of this paper was to perform a meta-analy...

Analysis of phenotype and gene mutation in three pedigrees with inherited antithrombin deficiency.

Inherited AT deficiency is an autosomal-dominant thrombophilic disorder usually caused by various SERPINC1 defects associated with a high risk of recurrent venous thromboembolism. In this article, the... Coagulation indices were examined on STAGO STA-R-MAX analyzer. The AT:Ag was analyzed by ELISA. All exons and flanking sequences of SERPINC1 were amplified by PCR. AT wild type and three mutant expres... The AT:A and AT:Ag of probands 1 and 3 were decreased to 49% and 52 mg/dL, 38% and 44 mg/dL, respectively. The AT:A of proband 2 was decreased to 32%. The SERPINC1 gene analysis indicated that there w... The p.I421T and p.M252T mutations affected the secretion of AT protein leading to type I AT deficiency of probands 1 and 3. The p.Leu417Gln mutation was responsible for the impaired or ineffective act...

Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency.

Hereditary antithrombin (AT) deficiency is an autosomal dominant inherited thrombophilia. In three pedigrees of hereditary type I AT deficiency, we identified novel variants c.126delC (p.Lys43Serfs...

Functional analysis of two abnormal antithrombin proteins with different intracellular kinetics.

Hereditary antithrombin (AT) deficiency type I causes venous thrombosis due to decreased levels of AT antigen in the blood. We identified one novel and one known abnormal variant in two unrelated Japa... Wild-type and variant AT expression vectors were constructed and transiently expressed in human embryonic kidney 293 cells, and AT antigen levels and N-glycosylation of cell lysates and culture medium... Genetic analysis identified a novel variant, c.613delC (p.Leu205Trpfs... The AT variants identified here synthesize abnormal AT proteins that exhibit suppressed secretion and impaired transport from the ER to the Golgi apparatus. These results provide clues that could help...